Behbahani Ali's most recent trade in Black Diamond Therapeutics Inc was a trade of 6,170 Common Stock done at an average price of $2.3 . Disclosure was reported to the exchange on June 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Black Diamond Therapeutics... | Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 2.33 per share. | 20 Jun 2025 | 6,170 | 77,150 (0%) | 0% | 2.3 | 14,376 | Common Stock |
| Monte Rosa Therapeutics Inc | Ali Behbahani | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2025 | 30,700 | 30,700 | - | - | Stock Option (Right to Buy) | |
| Black Diamond Therapeutics... | Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 30,550 | 30,550 | - | - | Stock Option (Right to Buy) | |
| Korro Bio Inc. | Ali Behbahani | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 6,010 | 6,010 | - | - | Stock Option (Right to Buy) | |
| Nkarta Inc | Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 46,000 | 46,000 | - | - | Stock Option (right to buy) | |
| CRISPR Therapeutics AG | Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 13,000 | 13,000 | - | - | Stock Option (Right to Buy) | |
| Arcellx Inc | Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 9,174 | 9,174 | - | - | Stock Option (right to buy) | |
| Black Diamond Therapeutics... | Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 1.88 per share. | 21 Mar 2025 | 7,646 | 70,980 (0%) | 0% | 1.9 | 14,374 | Common Stock |
| Black Diamond Therapeutics... | Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 2.50 per share. | 13 Dec 2024 | 5,750 | 63,334 (0%) | 0% | 2.5 | 14,375 | Common Stock |
| NeueHealth Inc. | Ali Behbahani | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 01 Oct 2024 | 185,595 | 556,782 | - | - | Warrant (Right to Buy) | |
| NeueHealth Inc. | Ali Behbahani | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 01 Oct 2024 | 61,865 | 185,594 | - | - | Warrant (Right to Buy) | |
| NeueHealth Inc. | Ali Behbahani | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 01 Oct 2024 | 61,865 | 185,594 | - | - | Warrant (Right to Buy) | |
| Black Diamond Therapeutics... | Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 4.78 per share. | 20 Sep 2024 | 3,007 | 57,584 (0%) | 0% | 4.8 | 14,373 | Common Stock |
| Adaptimmune Therapeutics P... | Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 1,144,686 | 1,144,686 | - | - | Option to purchase Ordinary Shares | |
| Black Diamond Therapeutics... | Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 4.98 per share. | 21 Jun 2024 | 2,887 | 54,577 (0%) | 0% | 5.0 | 14,377 | Common Stock |
| Nkarta Inc | Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 22,500 | 22,500 | - | - | Stock Option (right to buy) | |
| Monte Rosa Therapeutics Inc | Ali Behbahani | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 22,100 | 22,100 | - | - | Stock Option (Right to Buy) | |
| Korro Bio Inc. | Ali Behbahani | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 5,190 | 5,190 | - | - | Stock Option (Right to Buy) | |
| Black Diamond Therapeutics... | Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 30,550 | 30,550 | - | - | Stock Option (Right to Buy) | |
| CVRx Inc | Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 27,250 | 27,250 | - | - | Stock Option (right to buy) | |
| CVRx Inc | Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 20,961 | 20,961 | - | - | Stock Option (right to buy) | |
| CRISPR Therapeutics AG | Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 13,000 | 13,000 | - | - | Stock Option (Right to buy) | |
| Arcellx Inc | Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2024 | 8,011 | 8,011 | - | - | Stock Option (right to buy) | |
| Korro Bio Inc. | Ali Behbahani | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 56.00 per share. | 22 Apr 2024 | 17,857 | 1,090,793 | - | 56 | 999,992 | Common Stock |
| NeueHealth Inc. | Ali Behbahani | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Apr 2024 | 371,187 | 371,187 | - | - | Warrant (Right to Buy) | |
| NeueHealth Inc. | Ali Behbahani | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Apr 2024 | 123,729 | 123,729 | - | - | Warrant (Right to Buy) | |
| NeueHealth Inc. | Ali Behbahani | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Apr 2024 | 123,729 | 123,729 | - | - | Warrant (Right to Buy) | |
| Black Diamond Therapeutics... | Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 4.54 per share. | 15 Mar 2024 | 3,166 | 51,690 (0%) | 0% | 4.5 | 14,374 | Common Stock |
| Adaptimmune Therapeutics P... | Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2024 | 40,950 | 40,950 | - | - | Option to purchase Ordinary Shares | |
| Bright Health Group Inc | Ali Behbahani | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 19 Dec 2023 | 175,525 | 1,656,789 | - | - | Warrant (Right to Buy) | |
| Black Diamond Therapeutics... | Behbahani Ali | Director | Grant, award, or other acquisition of securities at price $ 2.73 per share. | 15 Dec 2023 | 4,455 | 48,524 (0%) | 0% | 2.7 | 12,162 | Common Stock |
| CVRx Inc | Ali Behbahani | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 14 Dec 2023 | 316 | 316 | - | 0.2 | 75 | Common Stock |
| CVRx Inc | Ali Behbahani | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2023 | 316 | 0 | - | - | Stock Option (right to buy) | |
| Bright Health Group Inc | Ali Behbahani | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Oct 2023 | 100,606 | 1,481,264 | - | - | Warrant (Right to Buy) | |
| Bright Health Group Inc | Ali Behbahani | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 15 Sep 2023 | 552,263 | 1,380,658 | - | - | Warrant (Right to Buy) | |
| Bright Health Group Inc | Ali Behbahani | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 11 Aug 2023 | 828,395 | 828,395 | - | - | Warrant (Right to Buy) | |
| Black Diamond Therapeutics... | Ali Behbahani | Director | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 05 Jul 2023 | 1,000,000 | 4,448,757 (12%) | 2% | 5 | 5,000,000 | Common Stock |
| Black Diamond Therapeutics... | Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 2.10 per share. | 16 Jun 2023 | 5,655 | 40,770 (0%) | 0% | 2.1 | 11,876 | Common Stock |
| Monte Rosa Therapeutics Inc | Ali Behbahani | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 20,500 | 20,500 | - | - | Stock Option (Right to Buy) | |
| Arcellx Inc | Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 11,459 | 11,459 | - | - | Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Ali Behbahani | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 13 Jun 2023 | 2,000,000 | 2,186,243 (8%) | 8% | 0 | Common Stock | |
| Mirum Pharmaceuticals Inc | Ali Behbahani | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 13 Jun 2023 | 30,000 | 30,000 (0%) | 0% | 0 | Common Stock | |
| Mirum Pharmaceuticals Inc | Ali Behbahani | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 13 Jun 2023 | 30,000 | 0 (0%) | 0% | 0 | Common Stock | |
| Mirum Pharmaceuticals Inc | Ali Behbahani | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 13 Jun 2023 | 135 | 135 (0%) | 0% | 0 | Common Stock | |
| Nkarta Inc | Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 22,500 | 22,500 | - | - | Stock Option (right to buy) | |
| CVRx Inc | Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2023 | 12,012 | 12,012 | - | - | Stock Option (right to buy) | |
| Arcellx Inc | Ali Behbahani | Director | Other type of transaction at price $ 0.00 per share. | 01 Jun 2023 | 113 | 339 | - | 0 | Common Stock | |
| Arcellx Inc | Ali Behbahani | Director | Other type of transaction at price $ 0.00 per share. | 01 Jun 2023 | 28 | 85 | - | 0 | Common Stock | |
| Black Diamond Therapeutics... | Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2023 | 16,500 | 16,500 | - | - | Stock Option (right to buy) | |
| Black Diamond Therapeutics... | Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 1.67 per share. | 16 Mar 2023 | 7,111 | 35,115 (0%) | 0% | 1.7 | 11,875 | Common Stock |
| Arcellx Inc | Ali Behbahani | Director | Other type of transaction at price $ 0.00 per share. | 20 Dec 2022 | 226 | 226 | - | 0 | Common Stock | |
| Arcellx Inc | Ali Behbahani | Director | Other type of transaction at price $ 0.00 per share. | 20 Dec 2022 | 57 | 57 | - | 0 | Common Stock | |
| Black Diamond Therapeutics... | Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 1.50 per share. | 16 Dec 2022 | 7,917 | 28,004 (0%) | 0% | 1.5 | 11,876 | Common Stock |
| Bright Health Group Inc | Ali Behbahani | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 17 Oct 2022 | 100,000 | 100,000 | - | - | Series B Convertible Perpetual Preferred Stock | |
| Bright Health Group Inc | Ali Behbahani | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 17 Oct 2022 | 37,700 | 37,700 | - | - | Series B Convertible Perpetual Preferred Stock | |
| Black Diamond Therapeutics... | Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 2.62 per share. | 16 Sep 2022 | 4,532 | 20,087 (0%) | 0% | 2.6 | 11,874 | Common Stock |
| Black Diamond Therapeutics... | Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 2.03 per share. | 17 Jun 2022 | 5,850 | 15,555 (0%) | 0% | 2.0 | 11,876 | Common Stock |
| Monte Rosa Therapeutics Inc | Ali Behbahani | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Minerva Surgical Inc | Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 2.41 per share. | 10 Jun 2022 | 49,792 | 58,279 | - | 2.4 | 119,999 | Common Stock |
| Black Diamond Therapeutics... | Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| CRISPR Therapeutics AG | Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 12,000 | 12,000 | - | - | Stock Option (Right to Buy) | |
| Nkarta Inc | Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 16,000 | 16,000 | - | - | Stock Option (right to buy) | |
| CVRx Inc | Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 26,985 | 26,985 | - | - | Stock Option (right to buy) | |
| Trevi Therapeutics Inc | Ali Behbahani | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 11 Apr 2022 | 3,000,000 | 3,000,000 | - | - | Pre-Funded Warrants | |
| Trevi Therapeutics Inc | Ali Behbahani | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.90 per share. | 11 Apr 2022 | 2,631,578 | 10,421,428 (58%) | 14% | 1.9 | 4,999,998 | Common Stock |
| Trevi Therapeutics Inc | Ali Behbahani | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.90 per share. | 11 Apr 2022 | 948,948 | 948,948 (5%) | 5% | 1.9 | 1,803,001 | Common Stock |
| Black Diamond Therapeutics... | Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 3.02 per share. | 18 Mar 2022 | 4,346 | 9,705 (0%) | 0% | 3.0 | 13,125 | Common Stock |
| Bright Health Group Inc | Ali Behbahani | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 03 Jan 2022 | 125,000 | 125,000 | - | - | Series A Convertible Perpetual Preferred Stock | |
| Bright Health Group Inc | Ali Behbahani | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 03 Jan 2022 | 75,000 | 75,000 | - | - | Series A Convertible Perpetual Preferred Stock | |
| Minerva Surgical Inc | Ali Behbahani | Director | 26 Oct 2021 | 4,196 | 5,181 | - | - | Common Stock | ||
| Minerva Surgical Inc | Ali Behbahani | Director | 26 Oct 2021 | 4,196 | 0 | - | - | Series D Preferred Stock | ||
| Minerva Surgical Inc | Ali Behbahani | Director | 26 Oct 2021 | 3,306 | 8,487 | - | - | Common Stock | ||
| Minerva Surgical Inc | Ali Behbahani | Director | 26 Oct 2021 | 3,306 | 0 | - | - | Series D Preferred Stock | ||
| Minerva Surgical Inc | Ali Behbahani | Director | 26 Oct 2021 | 742 | 3,306 | - | - | Series D Preferred Stock | ||
| Minerva Surgical Inc | Ali Behbahani | Director | 26 Oct 2021 | 704 | 985 | - | - | Common Stock | ||
| Minerva Surgical Inc | Ali Behbahani | Director | 26 Oct 2021 | 704 | 0 | - | - | Series C Preferred Stock | ||
| Minerva Surgical Inc | Ali Behbahani | Director | 26 Oct 2021 | 544 | 544 | - | - | Series D Preferred Stock | ||
| Minerva Surgical Inc | Ali Behbahani | Director | 26 Oct 2021 | 523 | 1,067 | - | - | Series D Preferred Stock | ||
| Minerva Surgical Inc | Ali Behbahani | Director | 26 Oct 2021 | 516 | 1,583 | - | - | Series D Preferred Stock | ||
| Minerva Surgical Inc | Ali Behbahani | Director | 26 Oct 2021 | 501 | 2,084 | - | - | Series D Preferred Stock | ||
| Minerva Surgical Inc | Ali Behbahani | Director | 26 Oct 2021 | 480 | 2,564 | - | - | Series D Preferred Stock | ||
| Minerva Surgical Inc | Ali Behbahani | Director | 26 Oct 2021 | 281 | 281 | - | - | Common Stock | ||
| Minerva Surgical Inc | Ali Behbahani | Director | 26 Oct 2021 | 281 | 0 | - | - | Series B Preferred Stock | ||
| Trevi Therapeutics Inc | Ali Behbahani | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 18 Oct 2021 | 1,851,852 | 1,851,852 | - | - | 7-Year Common Stock Warrant | |
| Trevi Therapeutics Inc | Ali Behbahani | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 18 Oct 2021 | 1,851,852 | 1,851,852 | - | - | 3.5-Year Common Stock Warrant | |
| Trevi Therapeutics Inc | Ali Behbahani | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 18 Oct 2021 | 1,851,852 | 7,789,850 (43%) | 10% | - | Common Stock | |
| Black Diamond Therapeutics... | Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 9.90 per share. | 17 Sep 2021 | 1,326 | 2,887 (0%) | 0% | 9.9 | 13,127 | Common Stock |
| CVRx Inc | Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2021 | 10,382 | 10,382 | - | - | Stock Option (right to buy) | |
| Bright Health Group Inc | Ali Behbahani | Ten Percent Owner | 28 Jun 2021 | 38,137,197 | 44,001,915 | - | - | Common Stock | ||
| Bright Health Group Inc | Ali Behbahani | Ten Percent Owner | 28 Jun 2021 | 14,942,061 | 14,942,061 | - | - | Common Stock | ||
| Bright Health Group Inc | Ali Behbahani | Ten Percent Owner | 28 Jun 2021 | 12,712,399 | 0 | - | - | Series D Preferred | ||
| Monte Rosa Therapeutics Inc | Ali Behbahani | Director, Ten Percent Owner | 28 Jun 2021 | 11,500,000 | 0 | - | - | Series B convertible preferred stock | ||
| Monte Rosa Therapeutics Inc | Ali Behbahani | Director, Ten Percent Owner | 28 Jun 2021 | 9,588,725 | 0 | - | - | Series A-2 convertible preferred stock | ||
| Bright Health Group Inc | Ali Behbahani | Ten Percent Owner | 28 Jun 2021 | 7,346,568 | 22,288,629 | - | - | Common Stock | ||
| Bright Health Group Inc | Ali Behbahani | Ten Percent Owner | 28 Jun 2021 | 5,864,718 | 5,864,718 | - | - | Common Stock | ||
| Bright Health Group Inc | Ali Behbahani | Ten Percent Owner | 28 Jun 2021 | 4,980,687 | 0 | - | - | Series D Preferred | ||
| Bright Health Group Inc | Ali Behbahani | Ten Percent Owner | 28 Jun 2021 | 3,673,284 | 47,675,199 | - | - | Common Stock | ||
| Monte Rosa Therapeutics Inc | Ali Behbahani | Director, Ten Percent Owner | 28 Jun 2021 | 3,257,328 | 5,973,296 | - | - | Common Stock | ||
| Monte Rosa Therapeutics Inc | Ali Behbahani | Director, Ten Percent Owner | 28 Jun 2021 | 2,715,968 | 2,715,968 | - | - | Common Stock | ||
| Bright Health Group Inc | Ali Behbahani | Ten Percent Owner | 28 Jun 2021 | 2,448,856 | 0 | - | - | Series E Preferred | ||
| Monte Rosa Therapeutics Inc | Ali Behbahani | Director, Ten Percent Owner | 28 Jun 2021 | 2,361,912 | 0 | - | - | Series C convertible preferred Stock |